EW Filing
144Filing Date: Jul 27, 2026

Edwards Lifesciences Corp (EW) · Proposed Sale (Form 144) SEC Filing

Insider Proposed Sale Notice

descriptionView SEC Filing
ACC: 0001921094-26-000758open_in_new

Sale Plan

Zovighian Bernard J
Officer, Director·Edwards Lifesciences Corp (EW)
Proposed
CommonNYSE
Shares2.92K
Est. DateJul 27
Market Value$245.1K
BrokerCharles Schwab & Co., Inc.
AcquisitionExercise & Hold · EDWARDS LIFESCIENCES CORPORATION
Acquired DateFeb 12, 2026
Amount Acquired2.92K
% Outstanding0.0005%
Exercise / Payment Details
Paid: Feb 12, 2026Method: Cash
Sales Past 3 Months Total $2.88M · 36.87K sh. expand_more
Jun
17
$46.0K
523 sh.
May
12
$2.83M
36.35K sh.
Signature & Compliance expand_more
Notice DateJul 27, 2026
Signature Bernard J Zovighian TTEE
Issuer Info expand_more
CompanyEdwards Lifesciences Corp
CIK0001099800
SEC File No.001-15525
Phone9492502500
AddressONE EDWARDS WAY, IRVINE, CA 92614

keid AI analysis is for reference only and does not constitute investment advice.